MedTrace Logo

Perioperative Anticoagulant Use for Surgery Evaluation Study

NCT02228798 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3135

Last updated 2019-06-28

No results posted yet for this study

Summary

The aim of the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study, is to establish a safe, standardized protocol for the perioperative management of patients with atrial fibrillation (AF) who are receiving a novel oral anticoagulant (DOAC) drug, either dabigatran, rivaroxaban or apixaban, and require an elective surgery/procedure.

Conditions

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Heart and Stroke Foundation of Canada

    collaborator OTHER

  • McMaster University

    lead OTHER

Principal Investigators

  • James Douketis, MD · McMaster University/St. Joseph's Healthcare

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-01
Primary Completion
2018-08-31
Completion
2018-08-31

Countries

  • United States
  • Belgium
  • Canada
  • Greece
  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02228798 on ClinicalTrials.gov